Stocks
REGENXBIO (RGNX) Debt/EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | 4.16 | -2.19 | 1.05 | 1.10 | 0.78 | 0.76 | ||
| Changes by years, y/y, % | +32% | -153% | -148% | +5% | -30% | |||
REGENXBIO. Debt/EBITDA
REGENXBIO. Debt/EBITDA, changes, %
REGENXBIO (RGNX) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 0.85 | 0.75 | 0.70 | 0.60 | 0.76 | 0.76 | ||
| Changes by years, y/y, % | -134% | -29% | -26% | -32% | -10% | |||
| Changes by quarters, q/q, % | -3% | -12% | -6% | -14% | +27% | |||
